Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Klein

Showing results (311-320 of 351) with videos related to

Pageof 36
Sort By:
Nature Metabolism|July 23, 2025
N-acetylaspartate from fat cells regulates postprandial body temperatureJessica B Felix, Pradip K Saha, Evelyn L de Groot, et al.
Hepatology Communications|June 18, 2021
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH StudyA Sidney Barritt, Stephanie Watkins, Norman Gitlin, et al.
Research Square|January 23, 2024
N-acetylaspartate from fat cells regulates postprandial body temperatureJessica B Felix, Pradip K Saha, Evelyn de Groot, et al.
Annals of Internal Medicine|August 4, 2010
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trialGary D Foster, Holly R Wyatt, James O Hill, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Adipocyte lipin 1 is positively associated with metabolic health in humans and regulates systemic metabolism in miceAndrew LaPoint, Jason M Singer, Daniel Ferguson, et al.
Nature Medicine|October 3, 2022
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Journal of Alzheimer'S Disease : JAD|January 18, 2021
Obesity and White Matter Neuroinflammation Related Edema in Alzheimer's Disease Dementia Biomarker Negative Cognitively Normal IndividualsMaria Ly, Cyrus A Raji, Gary Z Yu, et al.
Nature Medicine|March 18, 2023
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Journal for Immunotherapy of Cancer|June 25, 2021
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trialJohnny Duerinck, Julia Katharina Schwarze, Gil Awada, et al.
Journal of Diabetes and Its Complications|January 20, 2023
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, Javed Butler, George L Bakris, et al.
Pageof 36

Showing results (311-320 of 351) with videos related to

Sort By:
Pageof 36
Nature Metabolism|July 23, 2025
N-acetylaspartate from fat cells regulates postprandial body temperatureJessica B Felix, Pradip K Saha, Evelyn L de Groot, et al.
Hepatology Communications|June 18, 2021
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH StudyA Sidney Barritt, Stephanie Watkins, Norman Gitlin, et al.
Research Square|January 23, 2024
N-acetylaspartate from fat cells regulates postprandial body temperatureJessica B Felix, Pradip K Saha, Evelyn de Groot, et al.
Annals of Internal Medicine|August 4, 2010
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trialGary D Foster, Holly R Wyatt, James O Hill, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Adipocyte lipin 1 is positively associated with metabolic health in humans and regulates systemic metabolism in miceAndrew LaPoint, Jason M Singer, Daniel Ferguson, et al.
Nature Medicine|October 3, 2022
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Journal of Alzheimer'S Disease : JAD|January 18, 2021
Obesity and White Matter Neuroinflammation Related Edema in Alzheimer's Disease Dementia Biomarker Negative Cognitively Normal IndividualsMaria Ly, Cyrus A Raji, Gary Z Yu, et al.
Nature Medicine|March 18, 2023
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Journal for Immunotherapy of Cancer|June 25, 2021
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trialJohnny Duerinck, Julia Katharina Schwarze, Gil Awada, et al.
Journal of Diabetes and Its Complications|January 20, 2023
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, Javed Butler, George L Bakris, et al.
Pageof 36